Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
2(18%)
Results Posted
50%(3 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_1
4
36%
Ph phase_2
2
18%
Ph early_phase_1
1
9%
Ph not_applicable
4
36%

Phase Distribution

5

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 1Safety & dosage
4(36.4%)
Phase 2Efficacy & side effects
2(18.2%)
N/ANon-phased studies
4(36.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(6)
Terminated(2)
Other(1)

Detailed Status

Completed6
Terminated2
Active, not recruiting1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (9.1%)
Phase 14 (36.4%)
Phase 22 (18.2%)
N/A4 (36.4%)

Trials by Status

active_not_recruiting19%
unknown19%
recruiting19%
terminated218%
completed655%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11